Literature DB >> 5089955

The levels of factors II, VII, IX and X by antibody neutralization techniques in the plasma of patients receiving phenindione therapy.

K W Denson.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1971        PMID: 5089955     DOI: 10.1111/j.1365-2141.1971.tb00803.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


× No keyword cloud information.
  8 in total

1.  Antibody neutralizing material of factor VII during the first weeks of life.

Authors:  B Maak; J Frenzel
Journal:  Eur J Pediatr       Date:  1977-08-12       Impact factor: 3.183

2.  Inter-relationship among individual vitamin K-dependent clotting factors at different levels of anticoagulation.

Authors:  E Chan; L Aarons; M Serlin; A Breckenridge; M Rowland
Journal:  Br J Clin Pharmacol       Date:  1987-11       Impact factor: 4.335

3.  Factor X level in coumarin treated patients and in factor X deficiency as assayed with different techniques.

Authors:  A Girolami; A Brunetti; G Bareggi
Journal:  Blut       Date:  1972-08

Review 4.  Post-translational carboxylation of preprothrombin.

Authors:  B C Johnson
Journal:  Mol Cell Biochem       Date:  1981-08-11       Impact factor: 3.396

5.  Combined functional and immunochemical analysis of normal and abnormal human factor X.

Authors:  D S Fair; E F Plow; T S Edgington
Journal:  J Clin Invest       Date:  1979-10       Impact factor: 14.808

6.  Apparent "inhibition" as tested by means of the dilution curve system in patients with clotting defect due to liver damage.

Authors:  A Girolami; R Dal Bo Zanon; A Sticchi
Journal:  Blut       Date:  1977-09-29

7.  An immunological study of prothrombin in liver cirrhosis.

Authors:  A Girolami; G Patrassi; G Cappellato; V Quaino
Journal:  Blut       Date:  1980-07

8.  Factor IX antigen by radioimmunoassay. Abnormal factor IX protein in patients on warfarin therapy and with hemophilia B.

Authors:  A R Thompson
Journal:  J Clin Invest       Date:  1977-05       Impact factor: 14.808

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.